Viridian Therapeutics, Inc.

VRDN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001590750

SEC filings (opens in a new tab)

In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Viridian Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of VRDN: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	225	2	214	−9
Shares	112.4M	28.0K	136.0M	+23.7M (+21.1%)
Value	$2.21B	$547.2K	$2.50B	+$288.8M (+13.1%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (46)

Institutions that held Viridian Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to VRDN in Q2 2026
Institution	Shares	Value	% of portfolio
Caligan Partners LP	2,193,981	$40.3M	1.94%
Schonfeld Strategic Advisors LLC	793,508	$14.6M	0.08%
Boothbay Fund Management, LLC	541,058	$9.94M	0.19%
Emerald Advisers, LLC	537,328	$9.87M	0.23%
Ikarian Capital, LLC	425,000	$7.81M	1.28%
Emerald Mutual Fund Advisers Trust	395,546	$7.27M	0.26%
Blue Owl Capital Holdings LP	260,000	$4.78M	0.73%
Capital Fund Management S.A.	197,848	$3.63M	0.03%
F/M Investments LLC	134,761	$2.48M	0.13%
Lighthouse Investment Partners, LLC	120,000	$2.20M	0.07%
Alps Advisors Inc	111,572	$2.05M	0.01%
Jacobs Levy Equity Management, Inc	101,414	$1.86M	0.01%
Diadema Partners LP	100,000	$1.84M	0.65%
Y-Intercept (Hong Kong) Ltd	96,756	$1.78M	0.04%
Tudor Investment Corp Et Al	62,184	$1.14M	0.00%
Seven Grand Managers, LLC	50,000	$918.5K	0.04%
Gsa Capital Partners LLP	49,177	$903.0K	0.06%
Handelsbanken Fonder AB	45,400	$834.0K	0.00%
Quadrature Capital Ltd	45,078	$828.1K	0.01%
Doliver Advisors, LP	30,000	$551.1K	0.12%
Jupiter Topco LLC	27,472	$504.8K	0.00%
Persistent Asset Partners Ltd	25,490	$468.3K	0.15%
Quantinno Capital Management LP	21,949	$403.2K	0.00%
Public Employees Retirement System of Ohio	21,070	$387.1K	0.00%
Bayforest Capital Ltd	19,775	$363.3K	0.34%
Allstate Corp	14,955	$274.7K	0.00%
Nations Financial Group Inc,	11,272	$207.1K	0.01%
Virginia Retirement Systems Et Al	11,100	$203.9K	0.00%
Man Group plc	10,740	$197.3K	0.00%
Ghisallo Capital Management LLC	7,000	$128.6K	0.00%
Lazard Asset Management LLC	5,386	$98.9K	0.00%
Pacer Advisors, Inc.	1,816	$33.0K	0.00%
Federation des caisses Desjardins du Quebec	1,635	$30.0K	0.00%
Nykredit A/S	1,268	$23.3K	0.00%
IFG Advisory, LLC	272	$5.00K	0.00%
Simplex Trading, LLC	270	$4.96K	0.00%
SRS Capital Advisors, Inc.	238	$4.37K	0.00%
Quarry LP	230	$4.22K	0.00%
Silver Grove Financial Group, Inc.	116	$2.13K	0.00%
SJS Investment Consulting Inc.	110	$2.02K	0.00%
Ameritas Advisory Services, LLC	80	$1.47K	0.00%
Elequin Capital LP	71	$1.30K	0.00%
LRI Investments, LLC	46	$845	0.00%
Essential Partners LLC	31	$569	0.00%
Wealth Enhancement Trust Services, Inc.	20	$367	0.00%
Pinnacle Wealth Planning Services, Inc.	8	$147	0.00%

Sold out (55)

Institutions that held Viridian Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of VRDN in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Adage Capital Partners GP, L.L.C.	970,018	$19.0M
Loomis Sayles & Co L P	927,717	$18.1M
MPM Oncology Impact Management LP	649,873	$12.7M
ExodusPoint Capital Management, LP	330,390	$6.46M
ADAR1 Capital Management, LLC	304,422	$5.95M
Davern Capital Partners, LP	302,457	$5.92M
Raymond James Financial Inc	293,308	$5.45M
Marshall Wace, LLP	269,587	$5.27M
Rosalind Advisors, Inc.	250,401	$4.90M
Qube Research & Technologies Ltd	231,270	$4.52M
Propel Bio Management, LLC	210,163	$4.09M
Vivo Capital, LLC	166,288	$3.25M
Frontier Capital Management Co LLC	158,371	$3.10M
SEB Asset Management AB	156,957	$3.07M
Millennium Management LLC	140,595	$2.75M
Nicholas Investment Partners, LP	124,257	$2.43M
Moody Aldrich Partners LLC	95,235	$1.86M
Principal Financial Group Inc	75,200	$1.47M
Scientech Research LLC	65,080	$1.27M
Jane Street Group, LLC	60,815	$1.19M
Simplify Asset Management Inc.	56,231	$1.10M
Kopp Family Office, LLC	55,295	$1.08M
Walleye Capital LLC	54,398	$1.06M
Susquehanna Portfolio Strategies, LLC	52,571	$1.03M
Universal- Beteiligungs- und Servicegesellschaft mbH	48,822	$955.0K
CenterBook Partners LP	45,339	$886.8K
Virtu Financial LLC	38,217	$748.0K
Two Sigma Investments, LP	35,114	$686.8K
Captrust Financial Advisors	34,991	$684.4K
Campbell & CO Investment Adviser LLC	30,157	$589.9K
Jennison Associates LLC	28,059	$548.8K
Nomura Holdings Inc	22,205	$434.3K
Legato Capital Management LLC	21,159	$413.9K
EntryPoint Capital, LLC	20,450	$400.0K
Birchview Capital, LP	20,100	$393.2K
Suvretta Capital Management, LLC	16,700	$326.7K
Envestnet Asset Management Inc	16,519	$323.1K
Glenmede Trust Co NA	15,975	$312.5K
J. Goldman & Co LP	15,598	$305.1K
Fox Run Management, L.L.C.	12,980	$240.5K
Cinctive Capital Management LP	11,480	$224.5K
Entropy Technologies, LP	11,465	$224.3K
Toronto Dominion Bank	940	$18.4K
Antipodes Partners Ltd	834	$16.3K
Jones Financial Companies LLLP	511	$14.0K
Group One Trading, L.P.	625	$12.2K
Eastern Bank	330	$6.46K
SMA Capital LLC	203	$3.97K
Twin Peaks Wealth Advisors, LLC	30	$587
MAI Capital Management	19	$372
Fortitude Family Office, LLC	17	$333
Rossby Financial, LCC	11	$211
Stone House Investment Management, LLC	9	$176
Massmutual Trust Co FSB	8	$156
Keating Financial Advisory Services, Inc.	1	$20

Not filed for Q2 2026 yet (2)

Institutions that held Viridian Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VRDN in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Janus Henderson Group PLC	27,472	$536.7K
CWM, LLC	538	$10.5K